rethinkPeptides Search
Menu
Study breakdown

Could Anti-Obesity Drugs Treat Binge Eating Disorder?

ReviewPreliminary evidence
The takeaway

GLP-1 drugs may help binge eating disorder by addressing both weight and potentially the neurobiological underpinnings of compulsive eating, but evidence is still sparse.

Only 1 approved BED drug

Lisdexamfetamine is the only approved medication for binge eating disorder, and only in some countries

What the researchers found

Anti-obesity drugs, particularly GLP-1 receptor agonists, may have potential for treating binge eating disorder, but current evidence is limited and the psychological components of BED require special attention.

Why it matters

Binge eating disorder is extremely common but has very few approved treatments. If obesity drugs can address both the weight and the eating behavior, it could help millions of people.

The numbers in context

BED is described as the most prevalent form of disordered eating. Only lisdexamfetamine is currently approved for BED, and only in some countries.

How the study worked

Narrative review of existing literature on anti-obesity drugs and their potential role in binge eating disorder treatment.

Who was studied

People with binge eating disorder and/or obesity (review article)

What this study cannot tell us

This is a narrative review, not a systematic review or meta-analysis. Direct evidence for GLP-1 agonists in BED specifically is sparse.

How to read the evidence

Rated preliminary: narrative review exploring a hypothesis with limited direct evidence. No randomized trials of GLP-1 drugs specifically for BED.

When this study was published

Published in 2024. Reflects growing interest in GLP-1 drugs for conditions beyond diabetes and general obesity.

The bigger picture

With only one approved treatment available in limited countries, binge eating disorder is severely undertreated. If obesity drugs could address both weight and eating behavior, millions of people could benefit.

Questions still open

  • Do GLP-1 drugs reduce binge eating urges or just overall appetite?
  • Should BED-specific clinical trials be designed for GLP-1 drugs?

Common questions

Can Ozempic or Wegovy help binge eating?
There are theoretical reasons to think so — GLP-1 receptors exist in brain reward circuits — but specific clinical trials for binge eating disorder haven't been done yet.
What treatments exist for binge eating disorder?
Cognitive behavioral therapy is the gold standard. Lisdexamfetamine is the only approved drug, available in limited countries. Anti-obesity drugs are being explored.

Read the original research

Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges.

Alpha psychiatry, 25(3), 312-322

Citation

Riboldi, Ilaria; Carrà, Giuseppe. (2024). Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges.. Alpha psychiatry, 25(3), 312-322. https://doi.org/10.5152/alphapsychiatry.2024.241464